NIBIOHN and Shionogi announce discovery of novel antiviral antibody for SARS-CoV-2 Feb. 16, 2022 No Comments
US Department of Health & Human Services patents compounds for SARS-CoV-2 infection Feb. 11, 2022 No Comments
TMID enzymes as potential antiviral targets for the treatment of HHV infections Feb. 10, 2022 No Comments
New drug combinations with synergistic inhibitory activity against SARS-CoV-2 Feb. 9, 2022 No Comments
RSS